MeSH tree: E02.095.465.425.400
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain cancer in adults. In preclinical ...
May 13, 2026
0
10
Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to make new, healthy blood ...
May 12, 2026
0
15
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
May 12, 2026
0
6
University of Houston researchers are applying the principles of marketing science to public health, proposing that the way vaccines are "framed" could be a factor in overcoming hesitancy.
May 7, 2026
0
7
The scientific consensus is that vaccinations are neither causally nor statistically linked to autism. The US health authority CDC changed its official communication on this matter and instead emphasized a connection could ...
Apr 30, 2026
0
10
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and mount potent anti-tumor responses. These properties make them an attractive candidate for next-generation ...
Apr 30, 2026
0
47
Chimeric antigen receptor (CAR) T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer them to recognize tumor cells, multiply them in a laboratory and reinject ...
Apr 29, 2026
0
9
CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR-T regulatory T cells (CAR-Tregs), which weaken immune responses. Therefore, selectively targeting ...
Apr 29, 2026
0
9
Injections can be a source of stress and anxiety for children. The Willem-Alexander Children's Hospital is exploring ways to improve the experience. Together with illusionist Victor Mids and researchers from Leiden, they ...
Apr 29, 2026
0
6
A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell transplantation, according to the latest finding published by a team of scientists from the Hackensack ...
Apr 28, 2026
0
6
